In this work, the medium containing ionic products of dicalcium silicates (Ca2SiO4) for culturing MG63 cells was prepared by immersing a titanium alloy plate with the plasma sprayed Ca2SiO4 coatings in DMEM solution. The effect of the ionic products on cellular differentiation, collagen production, and local growth factors (prostaglandin E2 [PGE2] and transforming growth factor-β [TGF-β1]) of osteoblast-like MG63 cells were investigated. The normal DMEM was also used to culture MG63 cells as the control group. Differentiation of cell was evaluated by detecting alkaline phosphatase (ALP) activity and osteocalcin (OC) synthesis as well as their gene expression. Collagen production was analyzed by Sircol assay. The levels of PGE2 and TGF-β1 in culture medium were measured using enzyme-linked immunosorbent assay (ELISA). The gene expressions of TGF-β receptors (TGF-β RI and TGF-β RII) were also measured by real-time PCR technology. MG63 cells cultured in DMEM containing ionic products of Ca2SiO4 coating showed enhanced differentiation and increased collagen production. The results obtained from ELISA showed that the levels of PGE2 and TGF-β1 in experimental group were higher than that in control. The gene expression of TGF-β receptors was upregulated, indicating that more TGF-β1 bonded to their receptors which produce more effects on the osteoblastic activity, leading to enhanced differentiation and synthetic activity of osteoblast. It is concluded that ionic products of Ca2SiO4 coating may enhance cellular differentiation and collagen production by influencing TGF-β1 pathway.
JonesJRHenchLL. Effect of surfactant concentration and composition on the structure and properties of sol–gel-derived bioactive glass foam scaffolds for tissue engineering. J Mater Sci2003; 38(18): 3783–3790.
2.
JonesJRTsigkouOCoatesEEStevensMMPolakJMHenchLL. Extracellular matrix formation and mineralization on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells. Biomaterials2007; 28(9): 1653–1663.
3.
LossdörferSSchwartzZLohmannCHGreenspanDCRanlyDMBoyanBD. Osteoblast response to bioactive glasses in vitro correlates with inorganic phosphate content. Biomaterials2004; 25(13): 2547–2555.
XieYTLiuXYDingCXPaulK Chu. Bioconductivity and mechanical properties of plasma-sprayed dicalcium silicate/zirconia composite coating. Mater Sci Eng C2005; 25(4): 509–515.
AubinJE. Regulation of osteoblast formation and function. Rev Endocr Metabol Disorders2001; 2(1): 81–94.
10.
BonewardLFTransforming Growth Factor-β, In: BilezikianJPRaiszLGRodanGA (eds) Principles of bone biology, 2nd ed. San Diego: Academic Press, 2002, p.903–918.
11.
KassemMKveiborgMEriksenEF. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur J Clin Invest2000; 30(5): 429–437.
12.
RaiszLGFallPM. Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocr1990; 126(3): 1654–1659.
13.
SuzawaTMiyauraCInadaMMaruyamaTSugimotoYUshikuboF. The role of prostaglandin E receptor subtypes (EP1. EP2, Ep3, and EP4) in bone resorption: an analysis using specific agonist for the respective EPs. Endocrinology2000; 141(4): 1554–1559.
14.
GruberRNotheggerGHoGMWillheimMPeterlikM. Differential stimulation by PGE2 and calcemic hormones of IL-6 in stromal/osteoblastic cells. Biochem Biophys Res Commun2000; 270(3): 1080–1085.
15.
WeinrebMMachwateMShirNAbramovitzMRodanGAHaradaS. Expression of the prostaglandin E2 (PGE2) receptor subtype EP(4) and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue. Bone2001; 28(3): 275–281.
16.
KanekiHTakasugiIFujiedaMKiriuMMizuochiSIdeH. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts. J Cell Biochem1999; 73(1): 36–48.
17.
OpasEEGentileMARossertJAde CrombruggheBRodanGASchmidtA. Parathyroid hormone and prostaglandin E2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by elements of the pro-alpha1(I) collagen promoter. Bone2000; 26(1): 27–32.
18.
LiMHealyDRLiYSimmonsHACrawfordDTKeHZ. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone2005; 37(1): 46–54.
19.
JeeWSMaYF. The in vivo anabolic actions of prostaglandins in bone. Bone1997; 21(4): 297–304.
20.
Ramirez-YañezGOHamletSJonartaASeymourGJSymonsAL. Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis: an in vivo and in vitro study, Prostaglandins. Leukot Essen Fatty Acids2006; 74(3): 183–192.
21.
JorgensenNRHenriksenZSorensenOHCivitelliR. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids2004; 69(4): 219–226.
22.
WoodielFNFallPMRaiszLG. Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway. J Bone Miner Res1996; 11(9): 1249–1255.
23.
KawaguchiHPilbeamCCHarrisonJRRaiszLG. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Rel Res1995; 313: 36–46.
24.
BigiABracciBCuisinierFElkaimRFiniMMayerI. Human osteoblast response to pulsed laser deposited calcium phosphate coating. Biomaterials2005; 26(15): 2381–2389.
25.
BorsariVGiavaresiGFiniMTorricelliPTschonMChiesaR. Comparative in vitro study on a ultra-high roughness and dense titanium coating. Biomaterials2005; 26(24): 4948–4955.
26.
LohmannCHSagunRJrSylviaVLCochranDLDeanDDBoyanBD. Surface roughness modulates the response of MG63 osteoblast-like cells to 1,25-(OH)2D3 through regulation of phospholipase A(2) activity and activation of protein kinase A. J Biomed Mater Res1999; 47(2): 139–151.
27.
VermesCChandrasekaranRJacobsJJGalanteJORoebuckKAGlantTT. The effects of particulate wear debris, cytokines and growth factors on the functions of MG63 osteoblasts. J Bone Joint Surg Am2001; 83 A(2): 201–211.
28.
SunJYWeiLLiuXYLiJYLiBEWangGC. Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression. Acta Biomaterialia2009; 5(4): 1284–1293.
29.
Tullberg-ReinertHJundtG. In situ measurement of collagen synthesis by human bone cells with Sirius-Red based colorimetric microassay. Histochem Cell Biol1999; 112(4): 271–276.
30.
BoskeyALWrightTMBlankRD. Collagen and bone strength. J Bone Miner Res1999; 14: 330–335.
31.
PatriciaVMarivaldaMPAlfredoMGFatimaL. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials2004; 25(15): 2941–2948.
32.
SeabornCDNielsenFH. Silicon deprivation decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver. Biol Trace Elem Res2002; 89(3): 251–261.
33.
BosettiMZanardiLHenchLLCannasM. Type I collagen production by osteoblast like cells cultured in contact with different bioactive glasses. J Biomater Res2003; 64 A(1): 189–195.
34.
BirchallJD. The essentiality of silicon in biology. Chem Soc Rev1995; 24(5): 351–357.
35.
XynosIDAlasdairJEButteryLDK. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophy Res Commun2000; 276(2): 461–465.
36.
SunHLWuCTDaiKRChangJTangTT. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal dells on akermanite-bioactive ceramics. Biomaterials2006; 27(33): 5651–5657.
37.
TangQBrooksRRushtonNBestS. Production and characterization of HA and SiHA coatings. J Mater Sci: Mater Med2010; 21(1): 173–181.
38.
ReffittDMOgstonNJugdaohsinghRCheungHFJEvansBAJHampsonGN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone2003; 32(2): 127–135.
39.
HeberdenCDenisIPointillartAMercierT. TGF-β and calcitriol. Gen Pharmacol1998; 30(2): 145–151.
40.
KeetingPEOurslerMJWeigandKEBondeSKSpelsbergTCRiggsBL. Zeolite A increases proliferation, differentiation, and transforming growth factor beta production in normal adult human osteoblast-like cells in vitro. J Bone Miner Res1992; 7(11): 1281–1289.
41.
LilliCMarinucciLStabelliniGBelcastroSBecchettiEBalducciC. Biomembranes enriched with TGFβ1 favor bone matrix protein expression by human osteoblasts in vitro. J Biomed Mater Res2002; 63(5): 577–582.
42.
CentrellaMMcCarthyTLCanalisE. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem1987; 262(6): 2869–2874.
43.
HyytiainenMPenttinenCKeski-OjaJ. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci2004; 41(3): 233–264.
44.
ChangWParraMJiCLiuYEickelbergOMcCarthyTL. Transcriptional and post-transcriptional regulation of transforming growth factor β type II receptor expression on osteoblasts. Gene2002; 299(1-5): 65–77.
45.
CentrellaMJiCCasinghinoSMcCarthyTL. Rapid flux in transforming growth factor-β receptors on bone cells. J Biol Chem1996; 271(31): 18616–18622.
46.
PikingtonMFSimsSMDixonSJ. Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment. J Bone Miner Res2001; 16(7): 1237–1247.
47.
JanssensKDijkePJanssensSVan HulW. Transforming growth factor-β1 to the bone. Endocr Rev2005; 26: 743–774.
48.
HeldinCHMiyazonoKten DijkeP. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature1997; 390(6659): 465–471.
49.
ConconiMTTommasiniMBaigueraSDe CoppiPParnigottoPPNussdorferGG. Effects of prostaglandins E1 and E2 on the growth and differentiations of osteobalst-like cells cultured in vitro. Int J Mol Med2002; 10(4): 451–456.
